[1] PATRICIA K， LI Q X， DEAN L， et al. Resistance mutations in 23S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center[J].J Mol Biol， 1999， 294(1):93-101.
[2] JIN H. Novel Synthetic Antibacterial Agents-Linezolid[J].Chin Pharm J(中国药学杂志)， 2001， 36(8):571-572.
[3] WILLEMS R J， TOP J， SMITH D J， et al. Mutations in the DNA Mismatch Repair Proteins MutS and MutL of Oxazolidinone- Resistant or-Susceptible Enterococcus faecium[J].Antimicrob Agents Chemother， 2003， 47(1):3061-3066.
[4] BOZDOGAN B， APPELBAUM P C. Oxazolidinones: activity， mode of action， and mechanism of resistance[J].Int J Antimicrob Agents， 2004， 23(2):113-119.
[5] FUKUDA， Y. New approaches to overcoming bacterial resistance[J].Drugs Fut， 2009， 34(2):127-136.
[6] YAMANE K， ARAKAWA Y. Recent trend and research issues related to antimicrobial-resistant bacteria[J]. Masui， 2010， 59(1):4-16.
[7] ADAM R， RENSLO A， ANDY A， et al. A distal methyl substituent attenuates mitochondrial protein synthesis inhibition in oxazolidinone antibacterials[J].Bioorg Med Chem Let， 2007， 17(18):5036-5040.
[8] YANG Y， XU G， JI R， et al. Novel oxazolidone derivatives have powerful antibacterial activity， especially activity of resisting drug tolerant bacteria: China， 2006/1749256-A2[P]. 2006-03-22.
[9] LI R P， ZHOU W C， ZHOU W L. Synthesis and antibacterial activity of (S)-5-acetylaminomethyl-3-[(4-substituted-aminomethyl) phenyl]-2-oxazolindinone derivatives[J].Acta Pharm Sin (药学学报)， 2006， 41(5):418-425.
[10] BISWAJIT D， SONALI R， AJAY Y， et al. Synthesis and SAR of novel oxazolidinones:Discovery of ranbezolid[J].Bioorg Med Chem Let， 2005， 15(19):4261-4267.
[11] BRIJESH K S， MUKUL R， et al. Synthesis and in vitro antibacterial activities of novel oxazolidinones[J].Eur J Med Chem， 2008， 43(4):683-693.
[12] RUDRA S， YADAV A， Rao A， et al. Synthesis and antibacterial activity of potent heterocyclico -xazolidinones and the identification of RBx 8700[J].Bioorg Med Chem Let， 2007， 17(24):6714-6719.
[13] TAKHI M， SINGH G， MURUGAN， C， et al. Novel and potent oxazolidinone antibacterials featuring 3-indoly-lglyoxamide substitute -nts[J].Bioorg Med Chem Let， 2008， 18(18):5150-5155.
[14] BRAJ B L， VIDYA B L， BRIJESH K S， et al. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent[J].Bioorg Med Chem， 2004， 12(17):4557-4564.
[15] SHEILA I， HAUCK， CHRISTER C， et al. New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics[J].Bioorg Med Chem Let， 2007， 17(2):337-340.
[16] BRIJESH K S， RINA S， JAYENDRA Z P， et al. Synthesis and in vitro antibacterial activity of novel methyl amino piperidinyl oxazolidinones[J].Bioorg Med Chem Let， 2007， 17:5227-5232.
[17] SELVAKUMAR N， RAJULU G G， REDDY K C S， et al. Synthesis， SAR， and antibacterial activity of novel oxazolidinone analogues possessing urea functionality[J].Bioorg Med Chem Let， 2008， 18(2):856-860.
[18] KIM S J， MYUNG H， KYUNG H， et al. Synthesis and antibacterial activities of novel oxazolidinones having cyclicsulfonamide moieties[J].Bioorg Med Chem Let， 2008， 18(21):5815-5818.
[19] KIM J Y， BOYER F E， CHOY A L， et al. Synthesis and structure-activity studies of novel homomorpholine oxazolidinone antibacterial agents[J].Bioorg Med Chem Let， 2009， 19(2):550-553.
[20] CISKE F L， BARBACHYN M R， GENIN M J， et al. The effect of remote chirality on the antibacterial activity of indolinyl， tetrahydroquinolyl and dihydrobenzoxazinyl oxazolidinone[J]. Bioorg Med Chem Let， 2003， 13(23):4235-4239.
[21] CHOY A L， PRASAD J V， BOYER F E， et al. Synthesis and SAR of novel conformationally restricted oxazolidinones possessing Gram-positive and fastidious Gram-negative antibacterial activity. Part 2: Amino substitutions on heterocyclic D-ring system[J]. Bioorg Med Chem Let， 2007， 17(16):4699-4702.
[22] FREDERICK E， BOYER J V N， VARA P， et al. Synthesis and SAR of novel conformationally-restricted oxazolidinones possessing Gram-positive and fastidious Gram-negative antibacterial activity. Part 1: Substituted pyrazoles[J].Bioorg Med Chem Let， 2007， 17(16):4694-4698.
[23] EBNER D C， CULHANE J C， WINKELMAN T N， et al. Synthesis of novel oxazolidinone antimicrobial agents[J].Bioorg Med Chem， 2008， 16(5):2651-2656.
[24] TOKUYAMA R， TAKAHASHI Y， TOMITA Y， et al. Structure-Activity Relationship (SAR) Studies on Oxazolidinone Antibacterial Agents: Conversion of 5-Substituent on Oxazolidinone[J]. Chem Pharm Bull， 2001， 49(4):347-352.
[25] HLASTA D.New amidinomethyl and guanidinomethyl-oxazolidone compounds useful as antibacterial agents active against drug resistant bacteria: American， 2001/42229 A1[P]. 2001-06-14.
[26] PHILLIPS O A， UDO E E， SAMUEL S M， et al. Synthesis and structure antibacterial activity of triazolyl oxazolidinones containing long chain acyl moiety[J].Eur J Med Chem， 2008， 43(5):1095-1104.
[27] FAN H X， CHEN Y L， JIANG Z T， et al. Synthesis and biological evaluation of new N-linked 5-triazolyl methyl oxazolidinones[J].Eur J Med Chem， 2008， 43(8):1706-1714.
[28] DEMARAY J A， THUENER J E， DAWSON M N， et al. Synthesis of triazole-oxazolidinones via a one-pot reaction and evaluation of their antimicrobial activity [J].Bioorg Med Chem Let， 2008， 18(17):4868-4871.
[29] ZHAI X， WANG Y M， GONG P. Recent progress in the research of novel oxazolidinone antibacterial agents[J].J Shenyang Pharm Univ(沈阳药科大学学报)， 2006， 23(11): 739-744.
[30] RUDRA S， SANGITA F， GUJRATI A， et al. Synthesis and antibacterial activity of novel oxazolidinones with methyllene oxygen- and methylene sulfur-linked substituents at C5-position[J]. Bioorg Med Chem Let， 2007， 17(17):4778-4783.
[31] YING J， CUI A B， YA X， et al. Syntheses and antibacterial activity of a series of 3-(pyridine-3-yl)-2-oxazolidinone[J].Eur J Med Chem， 2005， 40(2):209-214.
[32] RENSLO A R， LUEHR G W， GORDEEV M F， et al. Developments in the identification of novel oxazolidinone antibacterial agents[J].Bioorg Med Chem， 2006， 14(12):4227-4240.
[33] SNYDER L B， MENG Z X， MATE R， et al. Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterials[J].Bioorg Med Chem Let， 2004， 14(18): 4735-4739.
[34] DU G J， CHEN D L， LU R J， et al. Synthesis and antibacterial activity of 3-(morpholinopyridyl)-5-substituted isoxazole derivatives[J].Chin J Org Chem(有机化学)， 2009， 29(10):1575-1581.
[35] GORDEEV M F， PATEL D V， BARBACHYN M R， et al. Antimicrobial quinolone derivatives and use of the same totreat bacterial infections: American， 2004/6689769 B2[P]. 2004-02-10.
[36] CHRISTIAN H， JEAN L S， CHRISTINE S， et al. Design，synthesis and biological evaluation of oxazolidinone-quinolone hybrids[J].Bioorg Med Chem， 2003， 11(10):2313-2319.
[37] ZHOU W， YU H， LI R. Fluoroquinolone-oxazolidone derivative， its preparation method and application: China， CN1948306-A[P]. 2007-04-18.
[38] HUBSCHWERLEN C， SPECKLIN J L， BAESCHLIN D K， et al. Structure-activity relationship in the oxazolidinone-quinolone hybrid series:influence of the central spacer on the antibacterial activity and the mode of action Christian Hubschwerlen[J].Bioorg Med Chem Let， 2003， 13(23):4229-4233.
[39] YU H J， ZHOU W C. Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin- 3-yl)-phenyl]-ethyl]-piperazin-1-yl}-fluoroquinolones[J]. Acta Pharm Sin (药学学报)， 2006， 41(10): 990-999.
[40] MA L， ZHOU W C， ZHOU W L. Synthesis and in vitro antibacterial activities of some bis-oxazolidinones[J].Chin J Pharm(中国医药工业杂志)， 2006， 37(10):649-652.
[41] SELVAKUMAR N， SUNIL K G， MALAR A A， et al. Synthesis， SAR and antibacterial studies on novel chalcone oxazolidinone hybrids[J].Eur J Med Chem， 2007， 42(4):538-543.
[42] WANG J W， HUANG J， WU Y， et al. Design and synthesis of novel thioether-linked carbapenem-oxazolidinone hybrids as potential antimicrobial agents[J].Lett Org Chem， 2008， 5(5):336-341.
[43] ZHOU J C， ASHOKE B， CHEN S L， et al. Design at the atomic level: Design of biaryloxazolidinones as potent orally active antibiotics[J].Bioorg Med Chem Let， 2008， 18(23):6175-6183.
[44] JI R Y， RONG S B， CHEN K X. Computer-Aided Drug Design[J].Chin Pharm J(中国药学杂志)， 1997， 32(11):571-572.
[45] LI Z C， L Q Z. Quantitative structure-activity relationship study on oxazolidinone antibiotics[J].Comp Appl Chem(计算机与应用化学)， 2006， 23(7):663-667.
[46] ZOU C， ZHOU L. Quantitative structure-activity relationship of oxazolidinone compounds[J].West Chin J Pharm Sci (华西药学杂志)， 2007， 22 (3):255-258.
[47] LOHRAY B B， NEHA G， BRIJESH K S， et al. 3D QSAR studies of N-4-arylacryloylpiperazin-1-yl-phenyl-oxazolidinones: A novel class of antibacterial agents[J].Bioorg Med Chem Let， 2006， 16(14):3817-3823.